文献速递肺外科

非局限性支气管扩张主要病灶的外科治疗

Surgery for predominant lesion in nonlocalized bronchiectasis.
PubMed 文献 · J Thorac Cardiovasc Surg · 2016-12-15

本研究回顾性分析了2010至2013年37例因非局限性支气管扩张接受开胸肺叶切除术的患者,主要手术指征为非局限性支气管扩张伴一个主要病灶、内科治疗失败且心肺储备充足。结果显示无手术死亡,8例(21.6%)出现术后并发症,术后急性感染频率、咯血频率及痰量均显著下降,62.2%患者术后无症状。结论认为对主要病灶行肺叶切除术安全,可显著缓解症状且满意度良好。

要点

  • 非局限性支气管扩张伴一个主要病灶、内科治疗失败且心肺储备充足者可考虑肺叶切除术。
  • 37例开胸肺叶切除术无手术死亡,术后并发症8例(21.6%),均无需再手术。
  • 术后急性感染、咯血频率及痰量显著下降,62.2%患者术后无症状。

核心结论

  • 对非局限性支气管扩张的主要病灶行肺叶切除术是安全的手术方式,可显著缓解症状且满意度良好。

研究设计与样本

  • 回顾性综述2010至2013年37例连续接受开胸肺叶切除术的非局限性支气管扩张患者的病历资料。
  • 主要手术指征为非局限性支气管扩张伴一个主要病灶、内科治疗失败及心肺储备充足。
  • 主要病灶通过术前计算机断层扫描和/或支气管镜检查确定。
  • 术前与术后症状采用配对方法进行比较分析。

主要发现

  • 患者平均年龄54.5 ± 6.4岁,无手术死亡。
  • 术后并发症发生于8例(21.6%)患者,包括1例脓胸、1例持续漏气及6例轻微一过性并发症,均无需再手术即可处理。
  • 肺叶切除术后剩余肺内残留支气管扩张区域中位范围为25%(范围12.5%-42.9%)。
  • 急性感染频率(5.3 ± 2.1/年 vs 1.8 ± 2.3/年)和咯血频率(4.9 ± 2.8/年 vs 1.1 ± 0.7/年)显著下降,痰量亦减少(37.1 ± 3.4 mL/天 vs 10.7 ± 4.6 mL/天)。

关键数值与推荐

  • 术后并发症8例(21.6%):脓胸1例、持续漏气1例、轻微一过性并发症6例。
  • 术后残留支气管扩张区域中位范围25%(范围12.5%-42.9%)。

临床怎么用

  • 对非局限性支气管扩张伴一个主要病灶、内科治疗失败且心肺储备充足的患者,可考虑对主要病灶行肺叶切除术以缓解症状。
  • 术前需通过计算机断层扫描和/或支气管镜确定主要病灶,并评估心肺储备。
  • 术后应告知患者残留支气管扩张区域可能仍存在,需关注感染与咯血等症状变化。

局限性

  • 本研究为单中心回顾性病历综述,样本量37例,证据级别有限。
  • 仅纳入接受开胸肺叶切除术的患者,未设非手术对照组。
  • 随访时间与长期复发情况原文未报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with nonlocalized bronchiectasis are encountered commonly; however, there is little information regarding surgical intervention in this patient population. The aim of this study was to evaluate symptomatic response and safety of anatomic resection of the predominant lesion via the use of lobectomy for the management of nonlocalized bronchiectasis. METHODS: We reviewed the medical records of 37 consecutive patients who underwent lobectomy via thoracotomy for nonlocalized bronchiectasis between 2010 and 2013. The main surgical indications were nonlocalized bronchiectasis with one predominant lesion, failure of medical treatment, and adequate cardiopulmonary reserve. The predominant lesion was determined by preoperative computed tomography and/or bronchoscopy. Preoperative symptoms were compared with postoperative symptoms and analyzed by the use of paired techniques. RESULTS: The mean patient age was 54.5 ± 6.4 years. There was no operative mortality. Postoperative complications occurred in 8 (21.6%) patients, including 1 with empyema, 1 with persistent air leak, and 6 with minor transient complications, all of which were manageable without any reoperation. After lobectomy, the median extent of residual bronchiectatic areas in the remaining lungs was 25% (range, 12.5%-42.9%). The frequency of acute infection (5.3 ± 2.1/year vs 1.8 ± 2.3/year) and hemoptysis (4.9 ± 2.8/year vs 1.1 ± 0.7/year) decreased significantly and the amount of sputum also decreased (37.1 ± 3.4 mL/day vs 10.7 ± 4.6 mL/day). Twenty-three (62.2%) patients were asymptomatic after surgery, 10 (27.0%) were symptomatic with clinical improvement, and 4 (10.8%) had no change or worsened. CONCLUSIONS: Lobectomy for the predominant lesion is a safe procedure in the surgical treatment of nonlocalized bronchiectasis and leads to significant relief of symptoms with good rates of satisfaction.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Dai J, Zhu X, Bian D, et al. Surgery for predominant lesion in nonlocalized bronchiectasis. J Thorac Cardiovasc Surg. 2016. PMID: 28073573. doi:10.1016/j.jtcvs.2016.12.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。